Nautilus Biotechnology, Inc.

Nautilus Biotechnology, Inc. (Nasdaq: NAUT) is a life-sciences company focused on single-molecule protein analysis and proteomics technology, based in Redwood City, California. The company entered the public markets through a merger with Endeavor Acquisition Corp, a special purpose acquisition company sponsored by Perceptive Advisors, whose S-1/A registration statement was filed with the SEC in July 2020. The SPAC completed its IPO in 2020, and the business combination with Nautilus Biotechnology closed in 2021, transitioning the combined entity to Nasdaq under the NAUT ticker. The company operates in the biotechnology sector, developing platform technology aimed at enabling large-scale proteomics research. Visit SpacDesk and sign up for full data on this SPAC merger, including deal terms, timeline, and comparable transactions.